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Abstract
Background: Lung cancer is the commonest cause of cancer death in the UK. Patients generally
present to their general practitioner, but the pathway of diagnosis from first symptom to diagnosis
has not been mapped. We performed a cohort study of 246 patients with lung cancer in Exeter,
Devon UK. All patients had their cancer symptoms, referrals and diagnoses identified and dated
using their doctors' records.
Results: Three main routes to diagnosis emerged. The first was the expected route of outpatient
referral; 150 (61% of the cohort) of patients took this route, although only 110 (45% of the whole
cohort, 73% of those referred to outpatients) were referred to a respiratory department. 56 (23%)
were admitted as an emergency, having previously described a lung cancer symptom to their
doctor. 26 patients (11%) had no symptom of lung cancer reported before their diagnosis. The
interval from first symptom to referral was similar across the different pathways. However, the
referral to diagnosis interval was longer in patients misdirected to other outpatient departments
(66 days, interquartile range 37,110) than those sent to respiratory clinics (29 days, 17,61) or
admitted as an emergency (16 days 8,40); p < 0.001.
Conclusion: Only a minority of lung cancer patients follow the traditional route to diagnosis.
Clinical and research efforts need to consider the alternative routes if they are to maximise their
impact on speed of diagnosis.
Background
Over 37,000 new lung cancers are diagnosed each year in
the UK [1]. Mortality is very high, with lung cancer the
leading cause of cancer deaths in the UK [1]. The poor sur-
vival reflects the intrinsically aggressive nature of the
tumour, with the shortest doubling time of the common
cancers, plus the fact that symptoms occur relatively late
in the growth of the cancer [2]. Many patients also delay
presenting their symptoms to their doctor, and the dura-
tion of symptoms is now recognised to be longer than pre-
viously thought [3,4]. Thus few patients are diagnosed at
a stage when they could be offered curative surgery [5].
Furthermore, no screening test has been found to be effec-
tive, and none is near to implementation, though trials are
in progress using spiral CT [5]. Most lung cancers present
with symptoms, and in the UK, most of these patients
present initially to their general practitioner (GP) [6].
Unlike for most other common cancers, there exists a pri-
mary care investigation for possible lung cancer which has
reasonable performance characteristics, namely the chest
X-ray, although false-negatives can occur in up to a quarter
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of primary care patients [7]. Theoretically, the availability
of chest X-rays should increase the proportion of patients
diagnosed by the conventional route of GP outpatient
referral to a respiratory physician, who then makes a tissue
diagnosis. This is utilised in the recommendations of the
National Institute of Clinical Effectiveness (NICE), which
suggest an X-ray for several clinical scenarios, such as hae-
moptysis or hoarseness [8]. However, it is possible that
these guidelines only help to identify more clinically obvi-
ous lung cancers. The level of compliance with guidance is
unknown, and no reduction in lung cancer mortality has
been seen following its introduction [9]. Given the
absence of a screening test, and the uncomfortable fact
that current guidance seems largely to identify those with
late staging, research efforts are being targeted at the early
symptoms of cancer [10]. Precise targeting of such efforts
requires an understanding of the pathways patients take
from first symptom to diagnosis. Such pathways have not
been mapped out, so we sought to address this evidence
gap.
Methods
This study was nested within a retrospective case-control
study aimed at identifying and quantifying clinical fea-
tures of lung cancer [2]. All 247 primary lung cancer cases
aged  ≥ 40 years, living in Exeter Primary Care Trust,
Devon, UK between 1998–2002, were identified from the
cancer registry at the Royal Devon & Exeter Hospital and
from computerised searches at all 21 general practices in
Exeter. Anonymised copies of the GP's records, referral let-
ters, specialist consultations and chest X-ray results were
taken. Nine features of lung cancer were identified from
the GP notes in the year before diagnosis: cough, haemo-
ptysis, dyspnoea, fatigue, loss of weight, loss of appetite,
clubbing, chest or rib pain and hoarseness. The pathway
from the first consultation in primary care with a feature
of cancer to diagnosis was mapped out. The date of diag-
nosis was taken as the date that histological proof was
obtained, or in the few that were diagnosed without his-
tology, the date that a respiratory physician gave the diag-
nosis [2]. As the intervals between first symptom and
diagnosis were not normally distributed, medians and
inter-quartile ranges were used for analysis, with median
tests for significance testing.
Results
A total of 247 patients were identified from the cancer reg-
istry and practice searches. One set of notes was unobtain-
able, so 246 were studied [2]. Of these, 171 (70%) were
male, with a mean age of 72 years and 75 (31%) female,
with a mean age of 68 years. The several possible path-
ways towards diagnosis are shown in Figure 1.
26 (11% of the total) of the patients had no feature of
lung cancer recorded in their notes in the year before diag-
nosis: although some of them were referred to a specialist,
lung cancer was not considered to be a likely explanation
for their ill-health. Of the remaining 220 patients, 150
(61% of the total) were referred to an outpatient clinic,
110 (45% of the whole cohort, 73% of those referred to
outpatients) of these to a respiratory physician. Four
patients were referred by a hospital consultant to respira-
tory clinic (internal referrals). 56 patients (23% of the
total) were admitted to hospital as an emergency, 52 of
these with respiratory symptoms and four without respi-
ratory symptoms. In 10 patients (4%) the precise referral
pathway to secondary care was impossible to determine.
The intervals between first symptom, referral and diagno-
sis are shown in Table 1.
The median (IQR) time to diagnosis for the 220 patients
with a symptom of lung cancer was 121 (53, 261) days.
For significance testing, the two types of emergency
admissions – self-referral and GP referral – were merged.
The interval from referral to diagnosis was highly signifi-
cantly different across the three main routes, with emer-
gency admissions having the shortest interval, and non-
respiratory outpatient referrals having the longest: p <
0.001. Differences in the interval between first presenta-
tion to primary care with a symptom of lung cancer and
referral were not significant across the three main referral
routes; p = 0.96. In contrast, the difference in the intervals
between first symptom presentation and diagnosis was
highly significant; p < 0.001.
Of the 110 patients who were referred to the respiratory
out-patients department 104 (95%) had had a chest X-ray
taken in primary care. In 87 (84%) of these malignancy
had been suggested in the X-ray report. Only 16 of 40
(40%) patients referred by the GP to other specialties had
had a preceding X-ray, a significant difference; p < 0.001.
Of the 210 patients whose referral to secondary care is
shown in Figure 1, 93 were before publication of the NICE
guidance, and 117 afterwards. After publication, a higher
proportion was referred to respiratory clinics, with 35
(37%) taking that route before guidance and 75 (64%)
afterwards. Also after publication, the number of emer-
gency admissions fell from 30 (32%) to 26 (22%), with
smaller changes in the other categories. This change was
significant: p = 0.003 (chi-squared with 4 degrees of free-
dom).
Discussion
This study describes the pathways lung cancer patients
took from first symptom recorded in primary care to diag-
nosis. There were three main routes. The majority (61%)
were referred by their GP for specialist investigation as
outpatients, though approximately one third of these
were to non-respiratory departments. However, thereBMC Family Practice 2008, 9:31 http://www.biomedcentral.com/1471-2296/9/31
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were improvements in the proportion referred to respira-
tory clinics in later years. Overall this means that only
45% of the cohort (110 of 246) took the standard path-
way. Almost all of these had had a chest X-ray taken in pri-
mary care. The next commonest route was by emergency
admission, accounting for nearly a quarter of the cohort.
The interval from the first recorded symptom and diagno-
sis was longest for misdirected referrals, and shortest for
those admitted as an emergency. The difference in speed
of diagnosis was in the interval after referral, not before
referral. The final route was for those without a respiratory
Lung cancer pathways from 1st consultation in primary care to diagnosis in secondary care Figure 1
Lung cancer pathways from 1st consultation in primary care to diagnosis in secondary care.
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symptom, many of whom were also admitted as an emer-
gency, but without predominant respiratory symptoms.
Strengths and weaknesses
This is a single cohort from one area, and may not be typ-
ical. It is relatively small, though it did identify all the can-
cers occurring over a five year period. It overlaps the
introduction of the first referral guidance for suspected
cancer sent to GPs in 2000, and does not take account of
the minor changes when these were revised in 2005 [8].
We do not know if the higher proportion referred to a res-
piratory clinic was due to the NICE guidance. However, it
seems unlikely, given the unchanged ease of access to pri-
mary care chest X-rays, and that respiratory departments
had been offering urgent appointments for suspected lung
cancer (largely based on abnormal chest X-rays) for many
years before the referral guidance was issued. We did not
have mortality data, so could not assess if there was any
association between the routes of diagnosis and clinical
outcomes. Furthermore, the data originate from the GP
records, and any omissions in medical recording of symp-
tom, investigations or referrals will have weakened this
study.
Comparison with previous literature
No primary care study has identified what proportions of
patients take the different routes to diagnosis. Much
recent work has concentrated on outpatient referrals, and
whether patients take the urgent or non-urgent route [9-
11]. In a large UK study of cancers in 1999 and 2000, All-
gar reported that 80% of lung cancer patients had seen
their GP before diagnosis, a lower percentage than
reported here [11]. These were self-reports rather than our
GP reports, perhaps explaining part of the differences.
That study also reported that patients who had seen their
GP before diagnosis experienced longer delays in diagno-
sis than those who had not: this was again not seen in the
study reported here. A Swedish cohort of 364 patients col-
lected in secondary care found 7% to be asymptomatic,
though how these patients had their cancer actually iden-
tified was not described [12]. Only one patient in the
study reported here was symptomless; this is not surpris-
ing as few screening chest X-rays are now performed.
Abnormal X-rays are the main trigger for referral to a res-
piratory physician, both in this study and another com-
paring urgent with non-urgent referrals [13].
Implications of the findings
The main finding is that only a minority of patients take
the standard route of GP referral to a respiratory physi-
cian. This is a smaller percentage of patients taking the
standard route than for colorectal, breast or prostate can-
cers [14-16]. In part this reflects the group who were
admitted as an emergency (though roughly the same pro-
portion of patients with colorectal cancer are first diag-
nosed as part of an emergency admission) [17]. The other
likely explanation is that lung cancer patients may be
more systemically unwell, with respiratory symptoms
either minor, or even absent. This may also explain those
patients who were referred to other departments. These
were also less likely to have been X-rayed. These patients
all had a symptom associated with lung cancer, but other
features may have predominated, making the GP omit an
X-ray. Whatever the explanation, this finding is impor-
tant, as most diagnostic initiatives have been concentrated
upon the standard pathway.
Nearly a quarter of patients were admitted to hospital as
emergencies. Emergency admissions have not previously
been reported as a common route to diagnosis in lung
cancer. Many of these admissions will have been for a res-
piratory infection, and the underlying cancer will only
have become apparent because of delayed recovery, or an
abnormality on the chest X-ray.
The third group was those without a respiratory symptom.
It is arguable that this group of unexpected diagnoses is
even smaller than reported, as many of these patients were
ill enough to be admitted to hospital, even if lung cancer
was not being considered. Every condition has atypical
Table 1: Intervals between symptom presentation, referral and diagnosis for lung cancer patients.
Department Time in days between the two events (median, IQR)
First symptom presented to primary care to 
referral
Referral to diagnosis First symptom presented to primary care to 
diagnosis
Outpatient referrals
Respiratory (n = 110) 51 (17, 165) 29 (17, 61) 107 (55, 216)
Other (n = 40) 37 (13, 197) 66 (37, 110) 149 (73, 317)
Emergency inpatient admissions
Self-referred (n = 11) 186 (38, 321) 15 (11, 37) 240 (48, 319)
GP referred (n = 45) 47 (6, 233) 16 (7, 59) 98 (45, 298)
Together (n = 56) 52 (7, 243) 16 (8, 40) 133 (45, 304)BMC Family Practice 2008, 9:31 http://www.biomedcentral.com/1471-2296/9/31
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presentations; that these are relatively rare in lung cancer
is helpful.
Lessons for expediting diagnosis of lung cancer
Several messages arise from this study. The first is for GPs,
in that some patients with lung cancer are referred to the
wrong speciality, and their diagnosis is delayed as a result.
This may be improved if there was a greater willingness to
take a chest X-ray. The NICE guidelines encourage this
practice, though it could be argued that the threshold for
ordering an X-ray is set too high in those recommenda-
tions.
The median interval between first recording of the cancer
symptom in the notes and eventual diagnosis is nearly
four months; around half of this is delay is in the GP mak-
ing a referral. This finding suggests that there is some
potential for expediting diagnosis in symptomatic lung
cancer patients. The median time from referral to diagno-
sis is short. This may reflect the smaller numbers of urgent
referrals made to respiratory clinics when compared to the
other common cancers. This is a major advantage of the
chest X-ray. Those who have an abnormal X-ray – and thus
qualify for urgent referral – have a much higher likelihood
of cancer than their counterparts with possible breast or
colorectal cancer. Thus, respiratory clinics should be able
to offer an efficient service – this study suggests they do.
Thirdly, researchers who wish to expedite lung cancer
diagnosis will have to consider the three different main
routes to diagnosis. Concentrating on the standard path-
way will miss around half of patients, including those
with the greatest delays in diagnosis.
Finally, policymakers need to address how patients can be
encouraged to attend when they have a lung cancer symp-
tom [3,4]. Early presentation may obviate some of the
emergency admissions, and allow more accurate direction
of referrals. This is not an easy task, as many of the symp-
toms of cancer carry a low risk [2], and there is a fine
dividing line between promoting early presentation, and
a need to avoid overwhelming GPs and radiology depart-
ments.
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